Myeloma genomics and Immuno-oncology

Novel targets and immune based therapy in myeloma

Upcoming trends in myeloma therapy

Recent advances in mantle cell lymphoma: Expert panel discussion

Lecture: PSA Screening - Where East meets West

Lecture: Current use of systemic therapies in localised disease

Lecture: Current standard of care in advanced disease

Lecture: Exploring the androgen signalling pathway in CRPC

Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for)

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against)